Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA

Don Thomas’s “secret weapons”—and how a 1970s BMT database continues to lead to new findings

In the 1970s, when E. Donnall Thomas was researching bone marrow transplantation, Fred Hutchinson Cancer Center started a database of transplant recipients.

April 11, 2025

Cancer Policy

Plan to Enhance Diversity is no longer a part of CCSG application

The latest notice of a funding opportunity for the Cancer Center Support Grants released by NCI no longer requires submission of a Plan to Enhance Diversity.

April 11, 2025

Cancer Policy

Federal judge nixes FDA’s LDT rule, says agency exceeded its authority

A federal judge ruled that the FDA lacks the statutory authority to regulate laboratory developed tests, finding squarely in favor of plaintiffs in the consolidated lawsuits brought by American Clinical Laboratories Association, Association for Molecular Pathology, and others. ASCP submitted an amicus brief supporting the plaintiffs.

April 11, 2025

In Brief

David Liu awarded 2025 Breakthrough Prize in Life Sciences

Howard Hughes Medical Institute Investigator David R. Liu was awarded the 2025 Breakthrough Prize in Life Sciences for developing two gene-editing technologies—known as base editing and prime editing—which enable the correction or replacement of virtually any genetic mutation, including those that cause countless human genetic diseases.

April 11, 2025

In Brief

Ira Mellman named president of research at Parker Institute

Ira Mellman was named president of research at the Parker Institute for Cancer Immunotherapy.

April 11, 2025

In Brief

Mark Cosentino to lead City of Hope’s new Kathleen and Robert Henderson Biorepository

Mark Cosentino has joined City of Hope as scientific director of the new Kathleen and Robert Henderson Biorepository, which is designed to be a best-in-class facility that collects and organizes tissue samples and other biological materials across City of Hope’s national system to further boost its cancer and other research.

April 11, 2025

Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA

YOU MAY BE INTERESTED IN

Don Thomas’s “secret weapons”—and how a 1970s BMT database continues to lead to new findings

Plan to Enhance Diversity is no longer a part of CCSG application

Federal judge nixes FDA’s LDT rule, says agency exceeded its authority

David Liu awarded 2025 Breakthrough Prize in Life Sciences

Ira Mellman named president of research at Parker Institute

Mark Cosentino to lead City of Hope’s new Kathleen and Robert Henderson Biorepository

Renew today!

Subscriber content

Never miss an issue!

Login